Insider trades

O'Neill Gilmore Neil

O'Neill Gilmore Neil made 0 buys and 3 sales on the open market in the last 12 months at Editas Medicine, Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Editas Medicine, Inc.
NASDAQ:EDIT
Director, CEO266KNov 11, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Editas Medicine, Inc.
NASDAQ:EDIT
Nov 11, 2026Sale21,164US$2.42US$51,122266KNov 13, 2026
Editas Medicine, Inc.
NASDAQ:EDIT
Sep 3, 2026Sale5,124US$3.04US$15,577243KSep 4, 2026
Editas Medicine, Inc.
NASDAQ:EDIT
Jun 3, 2026Sale15,380US$2.70US$41,526248KJun 5, 2026